• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Uncharacterized protein C19orf29 (C19orf29)

ACP13891

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13891 Target NameCACTIN
Target SynonymsC19orf29; Cactin; CS029_HUMAN; FLJ17482; FLJ59622; fSAPc; Functional spliceosome associated protein c; NY REN 24; NY REN 24 antigen; Renal carcinoma antigen NY-REN-24; Uncharacterized protein C19orf29FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-758
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8WUQ7
Background Information
  • Uniprot Id

    Q8WUQ7

  • Target Species

    Human

  • Target Name

    CACTIN

  • Target Full Name

    Splicing factor Cactin

  • Target Function

    Involved in the regulation of innate immune response. Acts as negative regulator of Toll-like receptor, interferon-regulatory factor (IRF) and canonical NF-kappa-B signaling pathways. Contributes to the regulation of transcriptional activation of NF-kappa-B target genes in response to endogenous proinflammatory stimuli.

  • Target Subcellular Location

    Nucleus. Cytoplasm, cytosol.

  • Target Protein Families

    CACTIN family

  • Target Synonyms

    C19orf29; Cactin; CS029_HUMAN; FLJ17482; FLJ59622; fSAPc; Functional spliceosome associated protein c; NY REN 24; NY REN 24 antigen; Renal carcinoma antigen NY-REN-24; Uncharacterized protein C19orf29

Inquire Recombinant Human Uncharacterized protein C19orf29 (C19orf29) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification